Department of Plastic and Hand Surgery and Laboratory for Tissue Engineering and Regenerative Medicine, University of Erlangen, Erlangen, Germany.
J Cell Mol Med. 2010 Oct;14(10):2350-8. doi: 10.1111/j.1582-4934.2010.01169.x.
The fields of tissue engineering (TE) and regenerative medicine (RegMed) are yet to bring about the anticipated therapeutic revolution. After two decades of extremely high expectations and often disappointing returns both in the medical as well as in the financial arena, this scientific field reflects the sense of a new era and suggests the feeling of making a fresh start although many scientists are probably seeking reorientation. Much of research was industry driven, so that especially in the aftermath of the recent financial meltdown in the last 2 years we have witnessed a biotech asset yard sale. Despite any monetary shortcomings, from a technological point of view there have been great leaps that are yet to find their way to the patient. RegMed is definitely bound to play a major role in our life because it embodies one of the primordial dreams of mankind, such as: everlasting youth, flying, remote communication and setting foot on the moon. The Journal of Cellular and Molecular Medicine has been at the frontier of these developments in TE and RegMed from its beginning and reflects recent scientific advances in both fields. Therefore this review tries to look at RegMed through the keyhole of history which might just be like looking 'back to the future'.
组织工程(TE)和再生医学(RegMed)领域尚未带来预期的治疗革命。经过二十年的极高期望和经常令人失望的回报,无论是在医学领域还是在金融领域,这个科学领域都反映了新时代的感觉,并暗示了重新开始的感觉,尽管许多科学家可能正在寻求重新定位。大部分研究都是由工业驱动的,因此,尤其是在最近两年金融崩溃之后,我们目睹了生物技术资产的大甩卖。尽管存在任何货币短缺,但从技术角度来看,已经取得了巨大的飞跃,但尚未找到通往患者的途径。RegMed 肯定会在我们的生活中发挥重要作用,因为它体现了人类的原始梦想之一,例如:青春永驻、飞行、远程通信和登月。《细胞与分子医学杂志》自成立以来一直处于 TE 和 RegMed 这些发展的前沿,并反映了这两个领域的最新科学进展。因此,这篇综述试图通过历史的关键孔来观察 RegMed,这可能就像是“回到未来”。